Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

D Czock, F Keller, FM Rasche, U Häussler - Clinical pharmacokinetics, 2005 - Springer
Glucocorticoids have pleiotropic effects that are used to treat diverse diseases such as
asthma, rheumatoid arthritis, systemic lupus erythematosus and acute kidney transplant …

Diversity of mechanism-based pharmacodynamic models

DE Mager, E Wyska, WJ Jusko - Drug metabolism and disposition, 2003 - ASPET
Pharmacodynamics is the study of the time course of pharmacological effects of drugs. The
field of pharmacodynamic modeling has made many advances, due in part to the relatively …

General pharmacokinetic model for drugs exhibiting target-mediated drug disposition

DE Mager, WJ Jusko - Journal of pharmacokinetics and …, 2001 - Springer
Drugs that bind with high affinity and to a significant extent (relative to dose) to a
pharmacologic target such as an enzyme, receptor, or transporter may exhibit nonlinear …

Basic concepts in population modeling, simulation, and model‐based drug development: part 3—introduction to pharmacodynamic modeling methods

RN Upton, DR Mould - CPT: pharmacometrics & systems …, 2014 - Wiley Online Library
Population pharmacodynamic (PD) models describe the time course of drug effects, relating
exposure to response, and providing a more robust understanding of drug action than single …

Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges

H Zou, P Banerjee, SSY Leung, X Yan - Frontiers in pharmacology, 2020 - frontiersin.org
With the advancement of technology, drug delivery systems and molecules with more
complex architecture are developed. As a result, the drug absorption and disposition …

[图书][B] Basic pharmacokinetics and pharmacodynamics: An integrated textbook and computer simulations

SE Rosenbaum - 2016 - books.google.com
Updated with new chapters and topics, this book provides a comprehensive description of
all essential topics in contemporary pharmacokinetics and pharmacodynamics. It also …

Target-mediated drug disposition and dynamics

DE Mager - Biochemical pharmacology, 2006 - Elsevier
Nonlinear pharmacokinetics and pharmacodynamics may result from several capacity-
limited processes and often represent complicating factors in characterizing the …

[HTML][HTML] Systems pharmacology–towards the modeling of network interactions

M Danhof - European Journal of Pharmaceutical Sciences, 2016 - Elsevier
Mechanism-based pharmacokinetic and pharmacodynamics (PKPD) and disease system
(DS) models have been introduced in drug discovery and development research, to predict …

AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia

SB Balachander, SW Criscione, KF Byth, J Cidado… - Clinical Cancer …, 2020 - AACR
Abstract Purpose: Targeting Bcl-2 family members upregulated in multiple cancers has
emerged as an important area of cancer therapeutics. While venetoclax, a Bcl-2–selective …

Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing …

SC Tate, S Cai, RT Ajamie, T Burke, RP Beckmann… - Clinical Cancer …, 2014 - AACR
Purpose: Selective inhibition of cyclin-dependent kinases 4 and 6 (CDK4/6) represents a
promising therapeutic strategy. However, despite documented evidence of clinical activity …